A federal court ruling has cleared the way for OxyContin maker Purdue Pharma to settle thousands of legal claims over the toll of opioids.

A woman who lost two sons to overdoses says she hopes a federal court clears the way for a settlement of lawsuits against OxyContin maker Purdue Pharma.

A judge has indicated he is moving forward with a plan for the owners of OxyContin maker Purdue Pharma to pump at least another $1.2 billion into a nationwide settlement of lawsuits against over the toll of opioids.

OxyContin maker Purdue Pharma has reached a nationwide settlement over its role in the opioid crisis.

With a settlement possibly near, a judge is giving the family that owns OxyContin maker Purdue Pharma 16 more days of protection from lawsuits over the toll of opioids.

A judge has kept lawsuits against OxyContin maker Purdue Pharma and members of the Sackler family who own it on hold until Feb. 1 but ordered the parties to negotiate a new settlement.

A federal judge’s decision to reject a multibillion dollar opioid settlement involving OxyContin maker Purdue Pharma is being hailed as a step toward justice by advocates who have long called for greater accountability for the family that owns the company.

A federal judge has rejected OxyContin maker Purdue Pharma’s sweeping deal to settle thousands of lawsuits over the toll of opioids.

Lawyers for a handful of states say members of the Sackler family who own OxyContin maker Purdue Pharma are abusing the bankruptcy process.

A book about a wealthy American family whose actions helped unleash the United States’ opioid epidemic has won Britain’s leading nonfiction book prize.

Objections to a historic settlement with Purdue Pharma are mounting in the form of appeals.

A judge formally approved a plan Friday to turn OxyContin maker Purdue Pharma into a new company no longer owned by members of the Sackler family and with its profits going to fight the opioid epidemic.

A Purdue Pharma lawyer says states would get more money from settling with the company than if they were allowed to continue their lawsuits against the OxyContin maker and members of the Sackler family who own it.

A lawyer for Purdue Pharma says the company's settlement plan is the only way to avoid long and expensive litigation.

OxyContin maker Purdue Pharma's plan to reorganize into an entity whose profits will be used to combat the U.S. opioid crisis got a big boost as 15 states have dropped their objections to the new business model.

WASHINGTON – Purdue Pharma, the company that makes OxyContin, the powerful prescription painkiller that experts say helped touch off an opioid epidemic, will plead guilty to three federal criminal charges as part of a settlement of more than $8 billion, Justice Department officials announced Wednesday. To Massachusetts Attorney General Maura Healey, the Justice Department “failed” and she said in a statement that she was not done with either Purdue or the Sacklers. Purdue will make a direct payment to the government of $225 million, which is part of a larger $2 billion criminal forfeiture. About half the states oppose that settlement, and also wrote Barr to ask him not to make the federal deal that includes converting Purdue into a public benefit corporation. As the maker of the best-known prescription opioid, Purdue is the highest-profile player in the opioid crisis, but it’s far from the other one.